Particle.news

Download on the App Store

ACIP Reconvenes to Vote on Key Vaccine Updates After Two-Month Delay

The panel addresses COVID-19 strategy shifts, RSV vaccine recommendations, and the future of critical public health programs.

Overview

  • The Advisory Committee on Immunization Practices (ACIP) resumed its meetings after a nearly two-month delay caused by administrative changes under HHS Secretary Robert F. Kennedy Jr.
  • The committee is deliberating a shift from universal COVID-19 booster recommendations to a risk-based approach targeting high-risk groups for the 2025–2026 season.
  • A proposal to lower the recommended age for RSV vaccination to adults 50 and older is under review to better protect vulnerable populations from severe complications.
  • Delays in ACIP meetings have raised concerns about the Vaccines for Children program, potentially jeopardizing free flu shots for children this fall.
  • Operational disruptions at the CDC, including staffing cuts and technical issues, have highlighted challenges in maintaining effective public health communication and resources.

Loading Articles...

Loading Quotes...